Clinical Trial Management System Market – Increasing Number of Clinical Trials is leading to Growth of the Clinical Trial Management System Market
The Clinical Trial Management System (CTMS) is an integrated software designed to manage the clinical trial data by biotech and pharma companies. It provides customizable functions with advanced technology and tools, which help to reduce time and cost during clinical trials by helping to manage large and complex clinical trial data. Moreover, clinical trial management systems provide various benefits such as easy access to data from various client locations, sharing of information, data maintenance and security, ease of administration and management of clinical trials at various locations by providing access to more than one user simultaneously.
Thus, advantages and benefits offered by CTMS during clinical trials are contributing to growth of the clinical trial management system market.
The global clinical trial management system market was valued at US$ 691.4 million in 2018 and it is expected to exhibit a CAGR of 12.8% during the forecast period (2019 – 2027).
Figure 1. Global Clinical Trial Management System Market Share (%), By Mode of Delivery
Source: Coherent Market Insights
Increasing number of product launches are expected to drive the clinical trial management system market growth
Several software tool providers are focusing on developing innovative data management systems for the healthcare sector, which is expected to drive growth of the clinical trial management system market. For instance, in December 2016, BGO Software launched Clinicubes CTMS, which is an advanced clinical trial management system. The system is designed to simplify processes associated with clinical trials.
Moreover, clinical trial service providers are focusing on development of CTMS for management of clinical trials. For instance, in May 2016, Bioclinica, Inc. launched OnPoint Direct, a clinical trial management system for biopharma companies and contract research organizations (CROs). The system offers cost-effective pricing structure that helps contract research organizations to adopt full-featured clinical trial management solutions.
Manufacturers of pharmaceuticals are focused on development of innovative CTMS, which is expected to be one of the primary factors contributing to growth of the clinical trial management system market over the forecast period. Moreover, major players in the market are focusing on integrating clinical trial management systems into its clinical trial operations.
However, pharma and biotech companies in low-income economies are still inclined towards use of conventional data management and tracking tools owing to lack of awareness about clinical trial management systems, and also cost concerns. These factors are projected to restrain the market growth over the forecast period.
Global Clinical Trial Management System Market Regional Analysis
North America is expected to exhibit significant growth in the clinical trial management system market owing to increasing number of clinical trials in the region. For instance, according to ClinicalTrials.gov, as of May 2017, the U.S. accounted for 36% of the clinical trials, and 245,188 studies were registered with ClinicalTrials.gov.
Europe is expected to witness significant growth in the clinical trial management system market, owing to increasing demand for CTMS by clinical research organizations in the region. For instance, in April 2019, SGS Life Sciences implemented the Veeva Vault CTMS, developed by Veeva Systems. With this system SGS has introduced state-of-the-art reporting capabilities and greater flexibility in conducting studies across the globe.
Thus, increasing number of clinical trials is projected to significantly drive demand for CTMS, which is expected to boost the clinical trial management system market growth.
Figure: Global Clinical Trial Management System Market Share, By Region, 2019-2027
Source: Coherent Market Insights
Global Clinical Trial Management System Market - Competitive Landscape
Some of the major companies offering clinical trial management systems are Medidata Solutions Inc., OpenClinica LLC., Forte Research Systems, Inc., Oracle Corporation, Datatrak International, Inc., Medrio, Inc., Parexel International Corporation, Bioclinica, Veeva Systems, and Crucial Life Sciences Data Solutions Inc.
The software and tools used to manage clinical trials are known as clinical trial management systems (CTMS). CTMS helps to reduce time and money and provide benefits such as secure real time access of data from multiple locations. There are two types of CTMS: cloud-based clinical trial management systems and on-premise clinical trial management systems.
Cloud-based CTMS offer 24x7 access to clinical trial data at any time, data administration, data security, data access from various client locations, sharing of information and technical support with advanced tools and trained staff. On-premise CTMS provides more security of data as it is stored and maintained at on-site or client locations. Moreover, on-premise CTMS provide customization in software as per business needs or client requirement, control on software upgrades and easy sharing of clinical trials data in-house in case of lack of connectivity across locations.
Increasing number of clinical trials and R&D across the globe are expected to fuel growth of the CTMS market, especially in developed regions. Furthermore, rising demand for CTMS for managing multiple clinical trials is expected to create opportunities for manufacturers to develop technologically advanced CTMS. This has led to an increase in demand for CTMS in contract research organizations, which is expected to drive growth of the clinical trial management systems (CTMS) market over the forecast period. For instance, in May 2019, COMBACTE launched clinical trial management system (CTMS). This new CTMS offers a professional tool for COMBACTE’s CLIN-Net team to optimize management of trials. Moreover, in March 2018, Theradex Oncology launched a clinical trial management system (CTMS) which is used to combine data & processes, and generate report on single platform. Furthermore, in January 2019, PHARMASEAL, a provider of clinical trial management and governance solutions launched Engility CTMS, a new generation clinical trial management system (CTMS).
The pharmaceutical sector is highly competitive and companies are focusing on expanding their consumer base in emerging economies. Furthermore, there is increasing demand for CTMS from companies worldwide as these systems help with the process of obtaining regulatory approvals for drug development and testing.
The cost for conducting clinical trials in emerging markets is comparatively low as compared to developed markets, therefore most of the global companies are focused on expansion of their CROs’ in the Asia Pacific region, which is expected to facilitate growth of the market in this region. For instance, in January 2018, the contract research organization (CRO), Biorasi, has opened its regional office in Japan to expand its clinical trial operations in Asia Pacific region.
Key features of the study:
“*” marked represents similar segmentation in other categories in the respective section.